Armin Kalenka

Dr. Armin Kalenka

District Hospital Bergstrasse
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2006 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
AKArmin Kalenka
Armin Kalenka
RFRobert E. Feldmann
Robert E. Feldmann
KOKevin Otero
Kevin Otero
MMMartin H. Maurer
Martin H. Maurer
KWKlaus F. Waschke
Klaus F. Waschke
FFFritz Fiedler
Fritz Fiedler
Sis and septic shock. Serum samples from 18 patients with sepsis and septic shock were obtained during the first 12 h after diagnosis of septic shock. Patients were grouped into SURV and NON-SURV on day 28. RESULTS: Seven patients survived and 11 patients died. Using proteome analysis, two-dimensional gel electrophoresis detected more than 200 spots per gel. A differential protein expression was discovered between SURV and NON-SURV, whereby protein alterations not yet described in sepsis were revealed. CONCLUSIONS: Our results show that proteomic profiling is a useful approach for detecting protein expression dynamics in septic patients, and may bring us closer to achieving a comprehensive molecular profiling compared with genetic studies alone....

1 May 2007 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
AKArmin Kalenka
Armin Kalenka
JHJochen Hinkelbein
Jochen Hinkelbein
RFRobert E. Feldmann
Robert E. Feldmann
WKWolfgang Kuschinsky
Wolfgang Kuschinsky
KWKlaus F. Waschke
Klaus F. Waschke
MMMartin H. Maurer
Martin H. Maurer
Recent studies showed changes in cerebral protein expression up to 3 days after desflurane anesthesia in rats. In the present study, we investigated the existence of persisting changes on the proteome level after sevoflurane anesthesia that persisted for as long as 28 days after anesthesia. Rats were anesthetized by spontaneous inhalation of 2.4% sevoflurane in air for 3 h. Animals (n = 6 for each group) were killed either directly, 72 h, or 28 days after anesthesia. Brains were removed and subjected to global protein expression profiling based on two-dimensional gel electrophoresis and mass spectrometry. Expression factors were compared to results from untreated conscious animals at each time point. Data were statistically analyzed by ANOVA (P < 0.01) and a cut of more than two-fold change in the expression factor. We found 11 protein spots differentially regulated directly after anesthesia. Seventeen proteins were differentially expressed 72 h after the anesthesia. Only one spot was differentially regulated 28 days after anesthesia. The plausible targets of these differentially regulated proteins can be attributed to synaptic vesicle handling and cell-cell communication. Sevoflurane induced relevant changes in protein expression profiles directly and 72 h after an anesthesia with 1 MAC. Twenty-eight days after the anesthesia, all proteins except one had returned to baseline levels of abundance.

1 June 2009 in Current Opinion in Anaesthesiology
Verified
Journal Article
Closed access
AKArmin Kalenka
Armin Kalenka
ASAnke Schwarz
Anke Schwarz
Parkinson's disease is the second most prevalent neurodegenerative disease and presents a particular anaesthetic challenge. The clinical features are described in detail, and recent advances in medical management and neurosurgical treatment options are highlighted. Deep brain stimulation (DBS) has experienced a renaissance for selected patients. Potential drug interactions with anaesthetics are described and recommendations are made about suitable anaesthetic techniques, especially for DBS. In addition to the classic DBS in an awake state, stimulation under modified general anaesthesia seems possible in selected patients who are not suitable for awake craniotomy. DBS is an attractive option for severely disabled patients with Parkinson's disease who pose a particular anaesthetic challenge.

1 November 2007 in Current Neurovascular Research
Verified
Journal Article
Closed access
PDF file
JHJochen Hinkelbein
Jochen Hinkelbein
RJRobert E. Feldmann Jr.
Robert E. Feldmann Jr.
APAnna Peterka
Anna Peterka
CSCharlotte Schubert
Charlotte Schubert
DSDominik Schelshorn
Dominik Schelshorn
AKArmin Kalenka
Armin Kalenka
The cause of brain dysfunction during sepsis and septic encephalopathy is still under ongoing research. Sepsis induced changes in cerebral protein expression may play a significant role in the understanding of septic encephalopathy. The aim of the present study was to explore cerebral proteome alterations in septic rats. Fifty-six male Wistar rats were randomly assigned to a sepsis group (coecal ligature and puncture, CLP) or a control group (sham). Surviving rats were killed 24 or 48 hours after surgery and whole-brain lysates were used for two-dimensional gel electrophoresis and subsequent protein identification. Differentially expressed proteins were identified by mass spectrometry. Using the Ingenuity Pathways Analysis (IPA) tool, the relationship and interaction between the identified proteins was analyzed. Mortality was 53 % in septic rats. No rat of the control group was lost. More than 1,100 spots per gel were discriminated of which 29 different proteins were significantly (2-fold, P < 0.01) changed: 24 proteins down-regulated after 24 hours; two proteins up-regulated and three down-regulated after 48 hours. IPA identified 11 of 35 differentially regulated proteins allocating them to an existing inflammatory pathway. In the analysis of septic rat brains, multiple differentially expressed proteins associated with metabolism, signaling, and cell stress can be identified via proteome analysis, that may help to understand the development of septic encephalopathy.

1 April 2006 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Open access
PDF file
AKArmin Kalenka
Armin Kalenka
MMM. H. Maurer
M. H. Maurer
RFR. E. Feldmann
R. E. Feldmann
WKW. Kuschinsky
W. Kuschinsky
KWK. F. Waschke
K. F. Waschke
Volatile anesthetics can alter cardiac gene and protein expression. Of those underlying molecular changes in gene and protein expression in the myocardium after exposure to volatile anesthetics that have been identified, some of them have been related to cardioprotection. We used two-dimensional gel electrophoresis and mass spectrometry to identify changes in the protein expression of the left ventricle myocardium of anesthesized rats. We maintained anesthesia for 3 h using isoflurane, sevoflurane or desflurane, respectively, at 1.0 minimum alveolar concentration (MAC) and dissected the left ventricular myocardium either immediately or 72 h after the end of anesthesia. We found changes of at least twofold in 106 proteins of the more than 1.600 protein spots discriminated in each gel. These differentially expressed proteins are associated with functions in glycolysis, mitochondrial respiration and stress response. No obvious difference could be observed between the patterns of differential expression of the three volatile anesthetics. We provide the first study of post-anesthetic protein expression profiles associated with three common volatile anesthetics. These volatile anesthetics promote a distinct change in the myocardial protein expression profile, whereby changes in the expression pattern still exist 72 h after anesthesia. These proteome changes are closely related to cardioprotection and ischemic preconditioning, indicating a common functional signaling of volatile anesthestics.

1 April 2005 in Der Anaesthesist
Verified
Journal Article
Closed access
PDF file
AKArmin Kalenka
Armin Kalenka
JHJ. Hinkelbein
J. Hinkelbein